Wolverine Trading, LLC Navidea Biopharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$0.18 - $0.3 $3,600 - $6,000	20,000 New	20,000 $4,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $1.1 $6,489 - $11,330	-10,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $1.2 $4,320 - $7,200	-6,000 Reduced 36.81%	10,300 $8,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $1.82 $5,600 - $10,192	5,600 Added 52.34%	16,300 $17,000
Q3 2021 Nov 12, 2021	BUY	$1.53 - $1.85 $16,371 - $19,795	10,700 New	10,700 $18,000
Q2 2021 Aug 06, 2021	SELL	$1.55 - $2.15 $27,590 - $38,270	-17,800 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.99 - $2.9 $4,179 - $6,090	2,100 Added 13.38%	17,800 $36,000
Q4 2020 Feb 12, 2021	BUY	$1.88 - $2.84 $2,632 - $3,976	1,400 Added 9.79%	15,700 $31,000
Q3 2020 Nov 13, 2020	SELL	$2.69 - $4.95 $15,333 - $28,215	-5,700 Reduced 28.5%	14,300 $41,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $4.16 $2,730 - $16,224	3,900 Added 24.22%	20,000 $76,000
Q1 2020 May 11, 2020	SELL	$0.76 - $1.54 $3,116 - $6,314	-4,100 Reduced 20.3%	16,100 $13,000
Q4 2019 Feb 12, 2020	BUY	$0.65 - $1.26 $13,130 - $25,452	20,200 New	20,200 $25,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.